Compare TTK HEALTHCARE with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PANACEA BIOTECH TTK HEALTHCARE/
PANACEA BIOTECH
 
P/E (TTM) x 22.1 5.2 425.0% View Chart
P/BV x 1.5 2.0 73.1% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 TTK HEALTHCARE   PANACEA BIOTECH
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
PANACEA BIOTECH
Mar-19
TTK HEALTHCARE/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,215354 343.6%   
Low Rs610138 441.5%   
Sales per share (Unadj.) Rs444.474.6 595.9%  
Earnings per share (Unadj.) Rs17.26.7 258.2%  
Cash flow per share (Unadj.) Rs27.615.5 178.3%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs177.957.2 311.0%  
Shares outstanding (eoy) m14.1361.25 23.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.13.3 62.3%   
Avg P/E ratio x52.936.8 143.7%  
P/CF ratio (eoy) x33.015.9 208.1%  
Price / Book Value ratio x5.14.3 119.3%  
Dividend payout %29.00-   
Avg Mkt Cap Rs m12,89415,061 85.6%   
No. of employees `0002.32.3 99.9%   
Total wages/salary Rs m1,3071,471 88.9%   
Avg. sales/employee Rs Th2,715.71,973.6 137.6%   
Avg. wages/employee Rs Th565.3635.6 88.9%   
Avg. net profit/employee Rs Th105.4176.8 59.6%   
INCOME DATA
Net Sales Rs m6,2794,567 137.5%  
Other income Rs m7845 173.0%   
Total revenues Rs m6,3564,612 137.8%   
Gross profit Rs m4962,030 24.4%  
Depreciation Rs m147540 27.2%   
Interest Rs m341,048 3.2%   
Profit before tax Rs m393486 80.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m14977 193.1%   
Profit after tax Rs m244409 59.6%  
Gross profit margin %7.944.4 17.8%  
Effective tax rate %37.915.9 239.2%   
Net profit margin %3.99.0 43.3%  
BALANCE SHEET DATA
Current assets Rs m2,7172,415 112.5%   
Current liabilities Rs m1,5719,077 17.3%   
Net working cap to sales %18.3-145.9 -12.5%  
Current ratio x1.70.3 650.3%  
Inventory Days Days3265 49.4%  
Debtors Days Days4771 65.8%  
Net fixed assets Rs m9918,333 11.9%   
Share capital Rs m14161 230.5%   
"Free" reserves Rs m2,3733,443 68.9%   
Net worth Rs m2,5143,504 71.8%   
Long term debt Rs m3461 0.7%   
Total assets Rs m4,15813,755 30.2%  
Interest coverage x12.61.5 861.8%   
Debt to equity ratio x00.1 1.0%  
Sales to assets ratio x1.50.3 454.8%   
Return on assets %6.710.6 63.0%  
Return on equity %9.711.7 83.0%  
Return on capital %16.938.7 43.8%  
Exports to sales %3.620.9 17.2%   
Imports to sales %0.58.1 6.1%   
Exports (fob) Rs m225954 23.6%   
Imports (cif) Rs m31372 8.3%   
Fx inflow Rs m2251,203 18.7%   
Fx outflow Rs m71467 15.2%   
Net fx Rs m154736 20.9%   
CASH FLOW
From Operations Rs m1731,049 16.5%  
From Investments Rs m97-54 -180.4%  
From Financial Activity Rs m-307-1,011 30.4%  
Net Cashflow Rs m-38-20 191.4%  

Share Holding

Indian Promoters % 65.4 74.5 87.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.6 616.7%  
FIIs % 5.2 1.3 400.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 23.6 109.3%  
Shareholders   12,723 10,259 124.0%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SHASUN PHARMA  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Slow Economy? There's Still Good Money to Be Made in the Markets(Podcast)

Indian stock markets mostly remained in the negative zone during the week except for Wednesday.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Here's Why I Recommended 15 Stocks in One Day Flat(Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

Will Algo Traders Take Away All Your Profits?(Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

These Rebirth of India Stocks Are Raring to Compete with Tesla(The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 20, 2020 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - JUBILANT LIFE SCIENCES COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS